TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 28 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $27,000 | -34.1% | 60,000 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $41,000 | -50.0% | 60,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $82,000 | -60.0% | 60,000 | -40.0% | 0.00% | -50.0% |
| Q3 2018 | $205,000 | +51.9% | 100,000 | +100.0% | 0.00% | +100.0% |
| Q2 2018 | $135,000 | +132.8% | 50,000 | +100.0% | 0.00% | 0.0% |
| Q1 2018 | $58,000 | -31.0% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $84,000 | -50.9% | 25,000 | -53.8% | 0.00% | -50.0% |
| Q3 2017 | $171,000 | +31.5% | 54,135 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $130,000 | -36.0% | 54,135 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $203,000 | +42.0% | 54,135 | +85.8% | 0.00% | 0.0% |
| Q4 2016 | $143,000 | -43.0% | 29,135 | -21.5% | 0.00% | -50.0% |
| Q3 2016 | $251,000 | +54.0% | 37,135 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $163,000 | -37.3% | 37,135 | 0.0% | 0.00% | -25.0% |
| Q1 2016 | $260,000 | -24.2% | 37,135 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $343,000 | +19.5% | 37,135 | +26.6% | 0.01% | 0.0% |
| Q3 2015 | $287,000 | – | 29,335 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 1,889,652 | $18,462,000 | 1.22% |
| WALL STREET ASSOCIATES | 250,000 | $2,442,000 | 0.47% |
| Eventide Asset Management | 403,912 | $3,946,000 | 0.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 485,000 | $4,738,000 | 0.18% |
| J. Goldman & Co LP | 170,000 | $1,661,000 | 0.14% |
| QVT Financial LP | 363,292 | $3,549,000 | 0.12% |
| Kinsight, LLC | 10,053 | $98,000 | 0.07% |
| Welch Group, LLC | 33,769 | $330,000 | 0.06% |
| Visium Asset Management, LP | 436,336 | $4,263,000 | 0.06% |
| Candriam S.C.A. | 135,300 | $1,322,000 | 0.03% |